Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes the conversion of skin fibroblasts into myoblasts and their differentiation into myotubes. The cell lines are derived from patients with neuromuscular disorders and can be used to investigate pathological mechanisms and to test therapeutic strategies.

Abstract

Investigations into both the pathophysiology and therapeutic targets in muscular dystrophies have been hampered by the limited proliferative capacity of human myoblasts. Several mouse models have been created but they either do not truly represent the human physiopathology of the disease or are not representative of the broad spectrum of mutations found in humans. The immortalization of human primary myoblasts is an alternative to this limitation; however, it is still dependent on muscle biopsies, which are invasive and not easily available. In contrast, skin biopsies are easier to obtain and less invasive to patients. Fibroblasts derived from skin biopsies can be immortalized and transdifferentiated into myoblasts, providing a source of cells with excellent myogenic potential. Here, we describe a fast and direct reprogramming method of fibroblast into a myogenic lineage. Fibroblasts are transduced with two lentiviruses: hTERT to immortalize the primary culture and a tet-inducible MYOD, which upon the addition of doxycycline, induces the conversion of fibroblasts into myoblasts and then mature myotubes, which express late differentiation markers. This quick transdifferentiation protocol represents a powerful tool to investigate pathological mechanisms and to investigate innovative gene-based or pharmacological biotherapies for neuromuscular disorders.

Introduction

Cellular models obtained directly from human tissues are useful to model many human genetic disorders, with the advantage of having the original genomic context and, in many cases, reproducing the same molecular and cellular hallmarks observed in the patients. In the field of neuromuscular disorders, muscle biopsies have been a great source of human myoblasts and have helped in the elucidation of pathological mechanisms. Additionally, they are an important tool for in vivo testing of drugs and gene therapies. On one hand, the derivation of myoblasts from muscle fragments is relatively easy. On the other hand, the culture and maintenance of primary myoblasts a....

Protocol

All experiments and biopsies were carried out following the ethical rules of the institutions involved under the approval of the Nationwide Children's Hospital Institutional Review Board.

1. Initiation of dermal fibroblasts culture

  1. Establishment of fibroblasts culture
    1. Aliquot 10 mL of fibroblast medium (Table 1) in 15 mL conical tubes. The skin biopsy should be placed and transported in this medium. The biopsy can be stored at 4 °C until it is .......

Representative Results

This protocol shows how to establish human skin-derived fibroblast cultures and convert them into myoblasts and then into differentiated myotubes. This type of cell line is extremely useful for the study of neuromuscular disorders and in vitro testing of potential therapies.

A schematic representation of the fibroblast conversion is shown in Figure 1. Figure 2A shows a fragment of skin and the fibroblasts emerging from it. Th.......

Discussion

To obtain FM cell lines with good quality, some steps are critical. The sooner the skin biopsy is processed, the greater the chances are to obtain healthy fibroblasts. The passage number of fibroblasts cultures is also important. Primary cells have limited proliferative capacity and after many passages, they enter in replicative senescence. Thus, it is better to have a stock of fibroblasts at a low passage number and transform cells at the earliest passage as possible.

Another important step .......

Acknowledgements

We would like to thank Dr. Vincent Mouly for sharing his knowledge in the past regarding the model. This work has been supported by the US National Institutes of Health National Institute of Neurological Disorders and Stroke (R01 NS043264 (K.M.F., and R.B.W.)), the US National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (P50 AR070604-01 (K.M.F., K.M., R.N., and N.W.). N.W. has received fellowship support from the Ohio State University/Nationwide Children's Hospital Muscle Group and the Philippe Foundation. This work was also supported by internal discretionary funds and part of the exon 2 skipping work has bee....

Materials

NameCompanyCatalog NumberComments
100 mm dishCorning430167
0.25% Trypsin-EDTA, phenol redThermo Fisher2500056
10X Phosphate buffered saline (PBS)Fisher ScientificBP3994
12-well plateCorning3513
20X Transfer bufferThermo FisherNP00061
20X Tris-acetate SDS running bufferThermo FisherLA0041
3-8% Tris-Acetate gelThermo FisherEA0378BOX
75 cm2 flaskCorning430641U
Antibiotic-Antimicotic 100XThermo Fisher15240062
Anti-myosin heavy chain, sarcomere antibodyDevelopmental Studies Hybridome BankMF20 supernatantDilution 1:50
AntioxidantThermo FisherNP0005
BCA Protein AssayThermo Fisher23227
ChloroformSigma-AldrichC2432
DAPIThermo FisherD3571Dilution 1:1000
DigitoninMillipore Sigma300410250MG
Dimethyl sulfoxideSigma-AldrichD2438
DMEM, High glucose, GlutaMAX supplement, PyruvateThermo Fisher10569044
DNAse I set (250U)Zymo Research CorporationE1010
Doxycycline HydrochlorideFisher ScientificBP2653-5
Dup2 human primersFw_5' GCTGCTGAAGTTTGTTGG
TTTCTC 3'
Rv_5' CTTTTGGCAGTTTTTGCC
CTGT 3'
Dystrophin antibodyAbcamab15277Dilution 1:200
Fetal bovine serumThermo Fisher16000
GlycineSigma-AldrichG8898
Goat anti-mouse, Alexa Fluor 488Thermo FisherA11001Dilution 1:1000
Halt Protease inhibitor cocktail 100XThermo Fisher78430
HemocytometerHausser Scientific3100
Hygromycin BThermo Fisher10687010
IRDye 680RD goat anti-Rabbit IgG (H+L)Li-Cor926-68071Dilution 1:5000
Lab-Tek II CC2 chamber slide systemThermo Fisher15852
LaemmliBioworld105700201
Lipofectamine 3000 Transfection ReagentThermo FisherL3000008
Matrigel GFR membrane matrixCorning354230
MethanolFisher ScientificA412P-4
Mr. Frosty Freezing ContainerThermo Fisher51000001
Nitrocellulose membrane 0.45 µmGE Healthcare Life Sciences10600002
Normal Goat serum controlThermo Fisher10000C
Odyssey Blocking Buffer (PBS)Li-Cor927-40003Blocking buffer for Western blot
Opti-MEM I Reduced Serum MediumThermo Fisher11058021
ParaformaldehydeSigma-Aldrich158127
PCR master mixThermo FisherK0172
Phosphatase inhibitorThermo FisherA32957
Precision Plus Protein Dual Color StandardsBio Rad1610374
PuromycinThermo FisherA1113803
Revert 700 Total Protein Stain for Western Blot NormalizationLi-Cor926-11021
RevertAid kitThermo FisherK1691
RNA Clean & Concentrator-25Zymo Research CorporationR1018
ScalpelsAspen Surgical372611
Skeletal Muscle Cell Differentiation mediumPromocellC23061
Skeletal Muscle Cell Growth mediumPromocellC23060
Triton X-100Acros Organics215682500
TRIzol reagentThermo Fisher15596026
Tween 20Fisher ScientificBP337500
Ultra low temperature freezerThermo Scientific7402
UltraPure 0.5M EDTA, pH 8.0Thermo Fisher15575020
Vectashield antifade mounting mediumVector LabsH1000

References

  1. Bigot, A., et al. Replicative aging down-regulates the myogenic regulatory factors in human myoblasts. Biology of the Cell. 100 (3), 189-199 (2008).
  2. Mamchaoui, K., et al.

Explore More Articles

Skin BiopsyFibroblastsMyoblastsMyotubesNeuromuscular DisordersLentivirusHTERTMYODDoxycyclineFibroblast MediumMyoblast Growth MediumDifferentiation Medium

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved